| 摘要 |
An HCV antibody contained in a specimen is measured by an immunoassay method by utilizing the specific binding affinity of a hepatitis C virus (HCV) antibody to an antigenic peptide having the amino acid sequence represented by the following formula (1), (2) or (3): Leu-His-Ile-Asn-Gln-Arg-Ala-Val-Val-Ala-Pro-Asp-Lys-Glu-Val-Leu-Tyr-Gl u-Ala-Phe-Asp-Glu-Met-Glu-Glu-Cys-Ser-Gln-Ala-Arg-Pro-Tyr-I le-Glu-Gln-Arg-Gln-Val-Ile-Ala-His Gln-Phe-Lys-Glu-Lys-Val-Leu .......(1> Glu-Ala-Phe-Asp-Glu-Met-Glu-Glu-Gys-Ser-Gln-Ala-Arg-Pro-Tyr-Ile-Glu-Gl n-Arg-Gln-Val-Ile-Ala-His-Gln-Phe-Lys-Glu-Lys-Val-Leu .......(2> Ser-Gln-Ala-Arg-Pro-Tyr-Ile-Glu-Gln-Arg-Gln-Val-Ile-Ala-His-Gln-Phe-Ly s-Glu-Lys-Val-Leu .......(3) According to the above method, it is possible to determine the serotype of the specimen simply and accurately, while suppressing a cross reaction or a non-specific reaction. As a result, for example, it is also possible to preliminarily predict the effect of interferon treatment in an accurate manner. <IMAGE> |
